Status:
COMPLETED
COVID-19 Pandemic on Health Care and Rehabilitation Outcomes
Lead Sponsor:
Istituto Ortopedico Rizzoli
Conditions:
Hip Fractures
Covid19
Eligibility:
All Genders
65+ years
Brief Summary
Fragility fracture is easily associated with a clinical worsening of patients in terms of quality of life and disability in the medium and long term. Following this traumatic event, more than half of ...
Detailed Description
The global health emergency due to the spread of COVID-19 has caused unprecedented pressure on the health systems of the various countries involved. COVID-19 has had a direct impact on the health stat...
Eligibility Criteria
Inclusion
- Patients diagnosed with fragility hip fracture such as pertrochanteric fracture, femoral neck fracture and subtrochanteric fracture
- Age 65 or older
Exclusion
- Patients diagnosed with a fragility hip fracture whose nursing record was not scanned at the time of the investigation
- Patients with fragility fractures of the diaphyseal and / or distal femur and acetabular fractures.
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT04882670
Start Date
February 1 2021
End Date
July 31 2021
Last Update
August 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Istituto Ortopedico Rizzoli
Bologna, BO, Italy, 40136